InvestorsHub Logo
Followers 512
Posts 59979
Boards Moderated 4
Alias Born 12/21/2009

Re: justsayingnow post# 2337

Tuesday, 11/10/2020 4:41:49 PM

Tuesday, November 10, 2020 4:41:49 PM

Post# of 2941
Yeah that must be it......

Remember before EL purchased SOLS they had no assets except the listing on OTC



So the question you have to ask is what did EL pay for their stake in Sollensys? Whatever that price is should reflect the value of the company, don't cha think?

From the 10Q.....

Pursuant to the terms of the SPA, Eagle agreed to purchase, and Custodian Ventures agreed to sell, 19,000,000 shares of the Company’s Series A Preferred Stock in exchange for payment by Eagle to Custodian Ventures of $230,000 (collectively with the other transactions in the SPA, the “Stock Purchase”). The Stock Purchase closed on August 5, 2020. The shares of Series A Preferred Stock, par value $0.001 per share, of the Company are convertible into shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a rate of 50 shares of Common Stock per share of Series A Preferred Stock, and has voting power on an as-converted basis (voting with the Common Stock as one class) and thus represents 65.4% of the voting power of all shares of stock of the Company.

Then there's this from the 11/2 8K.....

After giving effect to the Reverse Split, Eagle Lake Laboratories, Inc., the Company’s majority shareholder, continues to hold 95.8% of the Company’s issued and outstanding shares of common stock.

So how did EL pull off the miracle of buying 95.8% of a $700MM company for $230K?

Warren Buffet would like to know. So would I.